Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients

Pain Research and Treatment

Volumn 2014, Issue , 2014, Pages

  Schifilliti, Chiara ^a   Cucinotta, Lelio ^a   Fedele, Viviana ^a   Ingegnosi, Carmela ^a   Luca, Salvatore ^a   Leotta, Carmelo ^a  

^a Associazione MOVIS Onlus di Giarre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899539989     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2014/849623     Document Type: Article

References (41)

1. Ziegler D., Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 2009 32 2 S414 S419 2-s2.0-75549084221
2. Tesfaye S., Boulton A. J. M., Dyck P. J., Freeman R., Horowitz M., Diabetes neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010 33 10 2285 2293
3. Tesfaye S., Selvarajah D., Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes/Metabolism Research and Reviews 2012 28 1 8 14 2-s2.0-84856201567 10.1002/dmrr.2239
4. Cao X.-H., Byun H.-S., Chen S.-R., Cai Y.-Q., Pan H.-L., Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. Journal of Neurochemistry 2010 114 5 1460 1475 2-s2.0-77955143610 10.1111/j.1471-4159.2010. 06863.x
5. Skundric D. S., Lisak R. P., Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Experimental Diabesity Research 2003 4 4 303 312 2-s2.0-0346398463 (Pubitemid 38035569)
6. Aloe L., Leon A., Levi-Montalcini R., A proposed autacoid mechanism controlling mastocyte behaviour. Agents and Actions 1993 39 C145 C147 2-s2.0-0027313392 (Pubitemid 23276753)
7. Mazzari S., Canella R., Petrelli L., Marcolongo G., Leon A., N-(2-Hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. European Journal of Pharmacology 1996 300 3 227 236 2-s2.0-0029865544 10.1016/0014-2999(96)00015-5
8. Conti S., Costa B., Colleoni M., Parolaro D., Giagnoni G., Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. British Journal of Pharmacology 2002 135 1 181 187 2-s2.0-0036157693 (Pubitemid 34102111)
9. Costa B., Conti S., Giagnoni G., Colleoni M., Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. British Journal of Pharmacology 2002 137 4 413 420 2-s2.0-0036797445 10.1038/sj.bjp.0704900 (Pubitemid 35221894)
10. Ambrosino P., Soldovieri M. V., Russo C., Taglialatela M., Activation and desensitization of TRPV1 channels in sensory neurons by the PPAR α agonist palmitoylethanolamide. British Journal of Pharmacology 2013 168 6 1430 1444 10.1111/bph.12029
11. Khan G. M., Chen S.-R., Pan H.-L., Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 2002 114 2 291 299 2-s2.0-0036774152 10.1016/S0306-4522(02)00372-X (Pubitemid 35245410)
12. LoVerme J., la Rana G., Russo R., Calignano A., Piomelli D., The search for the palmitoylethanolamide receptor. Life Sciences 2005 77 14 1685 1698 2-s2.0-23044438547 10.1016/j.lfs.2005.05.012 (Pubitemid 41073662)
13. Petrosino S., Iuvone T., di Marzo V., N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities. Biochimie 2010 92 6 724 727 2-s2.0-77953291080 10.1016/j.biochi.2010.01.006
14. LoVerme J., Russo R., la Rana G., Fu J., Farthing J., Mattace-Raso G., Meli R., Hohmann A., Calignano A., Piomelli D., Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor- α Journal of Pharmacology and Experimental Therapeutics 2006 319 3 1051 1061 2-s2.0-33751166817 10.1124/jpet.106.111385
15. Paterniti I., Impellizzeri D., Crupi R., Morabito R., Campolo M., Esposito E., Cuzzocrea S., Molecular evidence for the involvement of PPAR-delta and PPAR-gamma in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma. Journal of Neuroinflammation 2013 10, article 20 10.1186/1742-2094-10-20
16. Khasabova I. A., Xiong Y., Coicou L. G., Piomelli D., Seybold V., Peroxisome proliferator-activated receptor? Mediates acute effects of palmitoylethanolamide on sensory neurons. The Journal of Neuroscience 2012 32 37 12735 12743 10.1523/JNEUROSCI.0130-12.2012
17. Raso G. M., Esposito E., Vitiello S., Iacono A., Santoro A., D'Agostino G., Sasso O., Russo R., Piazza P. V., Calignano A., Meli R., Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor- α Journal of Neuroendocrinology 2011 23 7 591 600 2-s2.0-79959254383 10.1111/j.1365-2826.2011.02152.x
18. Sasso O., Russo R., Vitiello S., Mattace Raso G., D'Agostino G., Iacono A., la Rana G., Vallée M., Cuzzocrea S., Piazza P. V., Meli R., Calignano A., Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain. Pain 2012 153 1 33 41 2-s2.0-84155172362 10.1016/j.pain.2011.08.010
19. de Filippis D., D'Amico A., Cipriano M., Petrosino S., Orlando P., di Marzo V., Iuvone T., Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacological Research 2010 61 4 321 328 2-s2.0-77649342807 10.1016/j.phrs.2009.11.005
20. De Filippis D., Luongo L., Cipriano M., Palazzo E., Cinelli M. P., de Novellis V., Maione S., Iuvone T., Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Molecular Pain 2011 7, article 3 2-s2.0-78650972394 10.1186/1744-8069-7-3
21. Costa B., Comelli F., Bettoni I., Colleoni M., Giagnoni G., The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPAR γ receptors and neurotrophic factors. Pain 2008 139 3 541 550 2-s2.0-53349089891 10.1016/j.pain.2008.06.003
22. Skaper S. D., Facci L., Fusco M., Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. Inflammopharmacology 2014 22 2 79 94 10.1007/s10787-013-0191-7
23. Skaper S. D., di Marzo V., Palmitoylethanolamide: biochemistry, pharmacology and therapeutic use of a pleiotropic anti-inflammatory lipid mediator. CNS & Neurological Disorders-Drug Targets 2013 12 1 4 6 10.2174/1871527311312010004
24. Costa B., Colombo A., Bettoni I., Comelli F., Palmitoylethanolamide relieves pain in a murine model of diabetic neuropathy. Proceedings of the 21st Annual Symposium on the Cannabinoids 2011 North Carolina, NC, USA International Cannabinoid Research Society, Research Triangle Park 12
25. Jack D. B., Aliamides: a new approach to the treatment of inflammation. Drug News and Perspectives 1996 9 2 93 98 2-s2.0-0030012234 (Pubitemid 26153190)
26. Calabrò R. S., Gervasi G., Marino S., Mondo P. N., Bramanti P., Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide. Pain Medicine 2010 11 5 781 784 2-s2.0-77953720756 10.1111/j.1526-4637.2010.00823.x
27. Guida G., de Fabiani A., Lanaia F., La palmitoiletanolamida (Normast) en el dolor neuropático crónico por lumbociatalgia de tipo compresivo: estudio clínico multicéntrico. Dolor 2010 25 35 42
28. Assini A., Laricchia D., Pizzo R., Pandolfini L., Belletti M., Colucci M., Ratto S., The carpal tunnel syndrome in diabetes: clinical and electrophysiological improvement after treatment with palmitoylethanolamide. 2010 17, supplement S3
29. Conigliaro R., Drago V., Foster P. S., Schievano C., Di Marzo V., Use of palmitoylethanolamide in the entrapment neuropathy of the median in the wrist. Minerva Medica 2011 102 2 141 147 2-s2.0-79957659495
30. Truini A., Biasiotta A., Di Stefano G., la Cesa S., Leone C., Cartoni C., Federico V., Petrucci M. T., Cruccu G., Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy. CNS & Neurological Disorders-Drug Targets 2011 10 8 916 920 2-s2.0-84857742677
31. Marini I., Bartolucci M. L., Bortolotti F., Gatto M. R., Bonetti G. A., Palmitoylethanolamide versus NSAID in the treatment of TMJ's pain. Journal of Orofacial Pain 2012 26 2 99 104
32. Gatti A., Lazzari M., Gianfelice V., Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogeneses. Pain Medicine 2012 13 9 1121 1130 10.1111/j.1526-4637.2012.01432.x
33. Vallejo R., Tilley D. M., Vogel L., Benyamin R., The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Practice 2010 10 3 167 184 2-s2.0-77954877647 10.1111/j.1533-2500.2010.00367.x
34. Feldman E. L., Stevens M. J., Thomas P. K., Brown M. B., Canal N., Greene D. A., A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994 17 11 1281 1289 2-s2.0-0028077808 (Pubitemid 24324972)
35. Lunetta M., Le Moli R., Grasso G., Sangiorgio L., A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Research and Clinical Practice 1998 39 3 165 172 2-s2.0-0031751021 10.1016/S0168-8227(98)00005-9 (Pubitemid 28255296)
36. Ziegler D., Hanefeld M., Ruhnau K. J., Meissner H. P., Lobisch M., Schutte K., Gries F. A., Schutte K., Ticinelli E.-C., Hahnzog B., Nehrdich D., Netten C., Dannehl K., Peukert M., Wessel K., Anders M., Brauning H., Brun M., Brunner E., Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α -lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995 38 12 1425 1433 2-s2.0-0028845524 10.1007/BF00400603
37. Padua L., Briani C., Jann S., Nobile-Orazio E., Pazzaglia C., Morini A., Mondelli M., Ciaramitaro P., Cavaletti G., Cocito D., Fazio R., Santoro L., Galeotti F., Carpo M., Plasmati R., Benedetti L., Schenone A., Marchettini P., Cruccu G., Validation of the Italian version of the neuropathic pain symptom inventory in peripheral nervous system diseases. Neurological Sciences 2009 30 2 99 106 2-s2.0-63749091680 10.1007/s10072-009-0025-y
38. Bouhassira D., Attal N., Fermanian J., Alchaar H., Gautron M., Masquelier E., Rostaing S., Lanteri-Minet M., Collin E., Grisart J., Boureau F., Development and validation of the neuropathic pain symptom inventory. Pain 2004 108 3 248 257 2-s2.0-12144288164 10.1016/j.pain.2003.12.024 (Pubitemid 38353047)
39. Morales-Vidal S., Morgan C., McCoyd M., Hornik A., Diabetic peripheral neuropathy and the management of diabetic peripheral neuropathic pain. Postgraduate Medicine 2012 124 4 145 153 10.3810/pgm.2012.07.2576
40. Hovaguimian A., Gibbons C. H., Clinical approach to the treatment of painful diabetic neuropathy. Therapeutic Advances in Endocrinology and Metabolism 2011 2 1 27 38 2-s2.0-79960037888 10.1177/2042018810391900
41. Gosselin R.-D., Suter M. R., Ji R.-R., Decosterd I., Glial cells and chronic pain. Neuroscientist 2010 16 5 519 531 2-s2.0-77957568217 10.1177/1073858409360822